Siemens Healthineers at ESCV 2022
We pioneer breakthroughs in healthcare.
For everyone. Everywhere.
For everyone. Everywhere.
Dates: Wed, Sep 7, 2022 – Sat, Sep 10, 2022
Location:
Manchester Central Convention Complex
Exchange Suite
Petersfield, Manchester, M2 3GX
Manchester, UK
Booth #36
Siemens Healthineers at ESCV 2022
Changing COVID-19 testing demands require clinical laboratories to keep up with an increasing number of patients, samples, and variants. Siemens Healthineers provides the flexibility you want for the clinical results you need with innovative, COVID-19 testing solutions.
While at ESCV 2022, explore our COVID-19 testing portfolio, from a highly sensitive RT-PCR test to high throughput or point of care antigen and antibody assays.
Our Products
At ESCV 2022, you will learn how Siemens Healthineers is pioneering breakthroughs in healthcare. For everyone. Everywhere.
From the lab to the point of care, Siemens Healthineers offers a full portfolio of COVID-19 testing solutions that consistently delivers sensitivity and performance—to get us to what’s next.
Large-scale Testing and Diagnosis
Clinicians use diagnostic tests to determine if people have current COVID-19 infections, enabling patient management decisions.
High-throughput Lab Antigen Testing
Molecular PCR Testing
Gold standard for accurate and early detection of infection.
Satellite Testing
Near-patient testing can be used to identify and isolate infected people more quickly.
Point-of-care Rapid Antigen Testing
Rapid antigen testing can help communities get ahead of the spread.
Management and Monitoring
Management and monitoring are critical in determining the full scope of the disease, combating the pandemic, and rebuilding public confidence.
High-throughput Lab Antibody Testing
Highly accurate for detection and monitoring of immune response through infection and in vaccination.
Point-of-care Antibody Testing
Our Booth at ESCV
How can your laboratory deliver more impactful results for the detection and management of COVID-19?
Visit our booth at ESCV to explore our portfolio of COVID-19 testing solutions to see how Siemens Healthineers is pioneering breakthroughs in healthcare. For everyone. Everywhere.
ESCV 2022 Siemens Healthineers Poster: Diagnostics for Seasonal Respiratory Viruses: Evaluation of the Analytical and Diagnostic Performance of the New FTD SARS-CoV-2/FluA/FluB/HRSV Assay
Our Symposium
ESCV 2022 Siemens Healthineers Symposium:
Diagnostics of seasonal respiratory viruses: what to expect for the upcoming season?
Date: 8 September 2022, Thursday
Time: 08:00 – 09:00
Hall: Plenary Hall
Speakers:
- Georgia Gioula, Ph.D. – Professor of Medical Microbiology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece (Chairwoman).
- Nathalie Kin Ph.D. – Scientist at Siemens Healthineers, Luxembourg.
We pioneer breakthroughs in healthcare. For everyone. Everywhere.
Thank you for joining us in Manchester, see you next year in Milan at ESCV 2023!
Did this information help you?
Distributed by Siemens Healthineers. CLINITEST Rapid COVID-19 Antigen Test: Not available for sale in the U.S.
This test has not been reviewed by the FDA. In the U.S., use of this test is limited to laboratories that are certified under Clinical Laboratory Improvement Amendments of 1988 (CLIA) to perform high-complexity testing.
The SARS-CoV-2 molecular and antibody tests have not been FDA-cleared or approved. These tests have been authorized by FDA under an EUA for use by authorized laboratories. The molecular test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. The antibody test has been authorized only for detecting the presence of antibodies against SARS-CoV-2, not for any other viruses or pathogens. These tests are only authorized. for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the. authorization is terminated or revoked sooner. Product availability may vary from country to country and is subject to varying regulatory requirements.
Fast Track Diagnostics assays are CE-marked for IVD use in the EU.
For research use only (RUO) in the U.S.
For Fast Track Diagnostics assays, please see the compatibility list to learn more about our compatible instruments. Customer is responsible for validating the assay on instruments listed in the compatibility list.
Product availability will vary country to country and is subject to varying regulatory requirements. Please contact your local representative for availability.